$15M Boost for CardioInsight, Heart-Mapping Firm

November 13, 2013
123 Views

CardioInsightFirst published on MedCityNews.comCardioInsight Technologies said today that it had secured “long-term strategic financing” that will allow it to complete ongoing clinical trial

CardioInsightFirst published on MedCityNews.comCardioInsight Technologies said today that it had secured “long-term strategic financing” that will allow it to complete ongoing clinical trials in Europe, advance product development programs and pursue regulatory clearance for its cardiac mapping technology in the U.S.

The financing will provide an initial investment of $15 million, the medical device company said.

Formed in 2006 with technology from Cleveland’s Case Western Reserve University, CardioInsight uses an electrode vest that’s worn by a patient to collect electrical data from the surface of the body. It then combines that data with anatomical images of the heart from a CT scan, to generate real-time, 3D, beat-by-beat maps of electrical activity in the heart.

Doctors may use cardiac mapping to help diagnose and treat electrical abnormalities of the heart, like arrhythmia and heart failure. Currently it’s done in an EP lab, where technicians insert catheters into various locations around the patient’s heart to identify the arrhythmia and correct it via ablation. CardioInsight positions its device as a non-invasive way to perform cardiographic mapping for diagnosis of arrhythmias.

The device, called ECVUE, got CE Mark clearance in 2011 and has been used on more than 800 patients in Europe, according to the company. It’s not yet been cleared by the FDA, and a company representative had not returned a call at time of publishing regarding progress with U.S. commercialization.

The new funding follows a $7.5 million Series C raised last year. Based on my calculations using past reports, the new $15 million would bring the total raised by the company to nearly $35 million. Among existing investors are Draper Triangle Ventures, Case Technology Ventures and Jumpstart Ventures (disclosure: Jumpstart is also an investor in MedCity Media).

Boston Scientific, St. Jude Medical and Johnson & Johnson subsidiary Biosense Webster are competitors in the cardiac mapping space.

You may be interested

The Benefits of Providing Homecare in Your Health System
Home Health
397 views
Home Health
397 views

The Benefits of Providing Homecare in Your Health System

Jennifer E. Landis - August 14, 2017

In-home health care, colloquially known as homecare, offers untold benefits for both patients and the health care professionals providing the…

Healthcare Tech Advances That All Clinics Should Use
Medical Devices
461 views
Medical Devices
461 views

Healthcare Tech Advances That All Clinics Should Use

Dennis Hung - August 12, 2017

Healthcare will always be important to employees and the government since the issues surrounding healthcare are inherently ethical and moral…

Balancing Smart Data With Cybersecurity for Hospitals
Hospital Administration
458 views
Hospital Administration
458 views

Balancing Smart Data With Cybersecurity for Hospitals

Kayla Matthews - August 11, 2017

It should come as no surprise that your discussions and interactions with physicians and health professionals influence diagnoses, prescriptions, visit…